Lexicon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…

Biotechnology
US, The Woodlands [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Lexicon Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Lexicon Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Lexicon Pharmaceuticals, Inc..

End of LXRX's Analysis
CIK: 1062822 CUSIP: 528872302 ISIN: US5288723027 LEI: - UEI: -
Secondary Listings
LXRX has no secondary listings inside our databases.